Earnings ·
Reports Q3 revenue of $19 million, up 35%, and raises full-year outlook low end to $68.5 million
MASS908 Devices Inc.
908 Devices Inc. reported third-quarter 2026 financial results with revenue reaching $19.0 million, a 35% increase year-over-year, driven by strong FTIR device sales and the addition of NIRLab revenue. The company shipped approximately 100 NIRLab devices in its first full quarter following acquisition, bringing total quarterly placements to a record 308 units. Recurring revenue accounted for $5.1 million, or 27% of total revenues. Gross margin held steady at 53%, while net loss from continuing operations narrowed to $4.6 million compared to $14.9 million in the prior year period. The company ended the quarter with $99.1 million in cash and no debt. Management raised the low end of its full-year 2026 revenue guidance range to $68.5 million, representing 22% to 25% growth compared to 2025. 908 Devices designs and manufactures handheld chemical analysis tools for health, safety, and defense applications.